Gain Therapeutics, Inc. (NASDAQ:GANX) People

Gain Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dov Goldstein
Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Coya Therapeutics, Inc. (Director · Since at least Dec 28, 2022); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Loxo Oncology Inc (CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past)
Independent Member · Since at least Mar 17, 2021
Gwen Melincoff
Other companies: Chemomab Therapeutics Ltd. (Board Director · Since at least Jun 1, 2026); Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Soleno Therapeutics, Inc. (Director · Apr 26, 2019 – May 25, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Aug 9, 2017 – May 16, 2024 · Past); Tobira Therapeutics Inc (Director · May 4, 2015 – Nov 1, 2016 · Past)
Independent Member · Since at least Mar 17, 2021
Charles Evan Ballantyne
Other companies: Agenus Inc. (CFO · Jun 17, 2015 – Jun 14, 2016 · Past); Theriva Biologics, Inc. (Chief Financial Officer · Feb 6, 2012 – Jan 8, 2015 · Past); Clinical Data Inc (EVP, CFO · Jun 14, 2007 – Apr 12, 2011 · Past)
Chief Financial Officer · Apr 10, 2023 – Apr 10, 2023 · Past
Claude Nicaise
Other companies: Filana Therapeutics, Inc. (Independent Director, Chairman of the Board · Since at least Dec 6, 2023); Chemomab Therapeutics Ltd. (Board Director · Since at least Mar 16, 2021); Sarepta Therapeutics, Inc. (Director · Since at least Jun 2, 2015)
Independent Member · Since at least Mar 17, 2021
Khalid Islam
Other companies: Fennec Pharmaceuticals Inc. (Chairman · Since at least Sep 11, 2017); Processa Pharmaceuticals, Inc. (Director · Nov 3, 2020 – Mar 31, 2022 · Past); Immunomedics Inc (Director · Mar 13, 2017 – Oct 23, 2020 · Past)
Chairman · Since at least Mar 17, 2021
Eric I Richman
Other companies: NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past)
Director · Since at least Mar 17, 2021
Hans Peter Hasler
Other companies: Minerva Neurosciences, Inc (Member · Since at least Dec 10, 2017); Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past)
Director · Since at least Mar 17, 2021
Gene Mack
Other companies: SELLAS Life Sciences Group, Inc. (CFO and Treasurer · Apr 20, 2018 – Apr 20, 2018 · Past)
Chief Executive Officer · Since at least Apr 5, 2024
Jeffrey Riley
Other companies: Theriva Biologics, Inc. (Chief Executive Officer, Director · Mar 16, 2010 – Nov 30, 2016 · Past)
Independent Member · Since at least Mar 17, 2021
Matthias Alder
Other companies: Sucampo Pharmaceuticals Inc (EVP, Gen. Council & Sec. · Mar 4, 2015 – Jun 30, 2017 · Past)
Chief Executive Officer, Director · Dec 23, 2021 – Mar 26, 2024 · Past
Apaar JammuDirector, Investor Relations and Public Relations · Since at least Oct 8, 2026
Gianluca FuggettaSee Remark · Since at least Dec 12, 2022
Investors:Gain TherapeuticsInc. Apaar Jammu Director, Investor Relations and Public · Since at least Oct 1, 2026
Manolo BellottoPresident and General Manager · Mar 17, 2021 – Mar 17, 2021 · Past
Salvatore CalabreseChief Financial Officer · Mar 17, 2021 – Mar 23, 2023 · Past